The PLGA@CCM@FA nanoparticle formulation triggered apoptosis in human triple-negative breast cancer cells by positively regulating cleaved caspase-3 and downregulating p-AKT expression [68]. The gene discussed is CASP3; the disease is triple-negative breast carcinoma.